Johnson & Johnson’s experimental coronavirus vaccine just passed a critical hurdle, as a group of top doctors and scientists voted unanimously on Friday to endorse …
Johnson & Johnson’s experimental coronavirus vaccine just passed a critical hurdle, as a group of top doctors and scientists voted unanimously on Friday to endorse the shot. After the vote, the Food and Drug Administration said it would work quickly to authorize the vaccine, allowing it to be given more widely. J&J has said it will have nearly 4 million doses ready to ship upon emergency authorization and is on track to deliver 100 million doses to the US by the end of June. Beyond the much-needed supply bump, public-health experts are eager to roll out the vaccine for its simplicity: It’s a single-dose vaccination that can be stored at typical refrigerator temperatures for several months.
